Nine Months Results of Strides Pharma Science (in Rs. Cr.) |
Dec '20 |
Dec '19 |
Dec '18 |
Dec '17 |
Dec '16 |
|
Net Sales/Income from operations |
1,223.97 |
1,232.41 |
1,102.88 |
1,026.38 |
1,522.48 |
|
Other Operating Income |
-- |
-- |
-- |
-- |
88.59 |
|
Total Income From Operations |
1,223.97 |
1,232.41 |
1,102.88 |
1,026.38 |
1,611.07 |
|
EXPENDITURE |
|
|
|
|
|
|
Consumption of Raw Materials |
669.08 |
654.08 |
674.88 |
566.95 |
708.59 |
|
Purchase of Traded Goods |
48.12 |
26.51 |
16.45 |
34.15 |
84.78 |
|
Increase/Decrease in Stocks |
-49.26 |
4.11 |
-34.63 |
29.41 |
-22.98 |
|
Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
Employees Cost |
199.09 |
158.38 |
174.32 |
183.59 |
299.45 |
|
Depreciation |
74.62 |
68.48 |
61.49 |
60.44 |
92.95 |
|
Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
Other Expenses |
257.64 |
241.27 |
210.65 |
201.64 |
345.77 |
|
P/L Before Other Inc. , Int., Excpt. Items & Tax |
24.68 |
79.58 |
-0.28 |
-49.80 |
102.51 |
|
Other Income |
65.69 |
72.90 |
58.20 |
139.36 |
118.86 |
|
P/L Before Int., Excpt. Items & Tax |
90.37 |
152.48 |
57.92 |
89.56 |
221.37 |
|
Interest |
47.43 |
48.39 |
37.78 |
70.53 |
85.76 |
|
P/L Before Exceptional Items & Tax |
42.94 |
104.09 |
20.14 |
19.03 |
135.61 |
|
Exceptional Items |
-- |
-- |
-2.01 |
22.43 |
-92.57 |
|
P/L Before Tax |
42.94 |
104.09 |
18.13 |
41.46 |
43.04 |
|
Tax |
12.78 |
18.76 |
2.54 |
-24.26 |
9.66 |
|
P/L After Tax from Ordinary Activities |
30.17 |
85.33 |
15.59 |
65.72 |
33.38 |
|
Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
Extra Ordinary Items |
-- |
-- |
-4.04 |
60.02 |
-- |
|
Net Profit/(Loss) For the Period |
30.17 |
85.33 |
11.55 |
125.74 |
33.38 |
|
Equity Share Capital |
89.63 |
89.55 |
89.55 |
89.50 |
89.37 |
|
Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
EPS Before Extra Ordinary |
|
|
|
|
|
|
Basic EPS |
3.37 |
9.53 |
1.29 |
7.35 |
3.74 |
|
Diluted EPS |
3.36 |
9.53 |
1.29 |
7.34 |
3.73 |
|
EPS After Extra Ordinary |
|
|
|
|
|
|
Basic EPS. |
3.37 |
9.53 |
1.29 |
7.35 |
3.74 |
|
Diluted EPS. |
3.36 |
9.53 |
1.29 |
7.34 |
3.73 |
|
Public Share Holding |
|
|
|
|
|
|
No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
a) Pledged/Encumbered |
|
|
|
|
|
|
- Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
b) Non-encumbered |
|
|
|
|
|
|
- Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited